Segment Information (Tables)

9 Months Ended

Mar. 31, 2017

Segment Reporting [Abstract]

Schedule of segment performance measures

Nine Months Ended March 31, 2017 and 2016:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2017
Net sales	$	201,686	$	121,253	$	120,759	$	-		$	443,698
Gross profit		56,424		19,867		27,672		-			103,963
Income (loss) before income taxes		13,912		7,299		13,599		(20,452	)		14,358
2016
Net sales	$	175,306	$	118,496	$	129,298	$	-		$	423,100
Gross profit		61,172		20,870		26,696		-			108,738
Income (loss) before income taxes		29,927		8,389		13,776		(8,472	)		43,620

Three months Ended March 31, 2017 and 2016:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2017
Net sales	$	99,816	$	43,821	$	46,491	$	-		$	190,128
Gross profit		25,300		7,255		9,764		-			42,319
Income (loss) before income taxes		5,007		3,036		5,034		(4,565	)		8,512
2016
Net sales	$	58,780	$	45,841	$	53,305	$	-		$	157,926
Gross profit		19,125		8,648		10,516		-			38,289
Income (loss) before income taxes		8,630		4,608		6,972		(4,666	)		15,544